Site Search

... need to make clinical research a standard healthcare option instead of something that physicians and cancer patients view as a ‘Hail Mary’ care approach.,” said Brendan Early, vice president of clinical development for PRA Health Sciences. “This problem is multifactorial, with varying views. Today’s forum was a very effective opportunity to look at the issue from ... Center, Michael Kastan, MD, PhD , executive director, Duke Cancer Institute, Karen Winkfield, MD, PhD , associate director for office of cancer health equity, Wake Forest Baptist Medical Comprehensive Cancer Center, Greg Licholai, MD, MBA , chief medical information officer, PRA Health ...

... at the University of Wisconsin and American Cancer Society research scholar, spoke during the event and urged lawmakers to expand access to health care and approve critical research funds. “Today, advancements in cancer research are saving more lives than ever. Strong and consistent federal ...

... lack of physical activity. Governor Paterson is in tune with the latest science and recognizes the very real threat that obesity poses to the health of New Yorkers. Cancer and obesity are linked, and by educating people about the risk of a high calorie, high fat diet and promoting prevention, we can reduce cancer rates and control health care costs. We thank Governor Paterson for his leadership on this issue and urge the Senate and Assembly to pass this legislation swiftly.” ### ...

... them, giving doctors the right amount of information to make a therapy decision. The National Cancer Institute at the National Institutes of Health has recognized the potential impact of targeted NGS on cancer and is using it to help match patients to ongoing drug trials through its ... Doctors and healthcare networks have a responsibility to their patients to provide the most effective innovations so patients get the right care.  The issue of economics, on the other hand, is harder to overcome. NGS-based tests provide a significantly higher value to patients and ... Medicare and Medicaid – can help tremendously by coordinating NGS-focused trials across multiple labs to exponentially expand patient and health economics data. The information they gather would help establish clinical utility and cost justification, which is what insurers rightfully ...